U.S. Electrical Stock News

OTCPK:LNWO
OTCPK:LNWOHospitality

Is There Opportunity in Light & Wonder After 14.8% Drop So Far in 2025?

Ever wondered whether Light & Wonder is offering hidden value, or if the current price leaves little room for upside? You are not alone. Many investors are asking the same question. Recently, the stock has seen some turbulence, losing 4.2% over the last week and falling 14.8% year-to-date, even as it remains up more than 100% over the past five years. There has been plenty happening in the industry, from new product launches to shifting market regulation, both of which have put Light &...
NYSE:GETY
NYSE:GETYInteractive Media and Services

Can Getty Images (GETY) Leverage AI Partnerships to Reinforce Its Competitive Advantage?

On October 31, 2025, Perplexity announced a multi-year global licensing agreement with Getty Images, enabling the integration of Getty's creative and editorial images into Perplexity's AI-powered search and discovery tools. This collaboration highlights the growing importance of ethical licensing and copyright attribution as AI platforms integrate premium visual content for enhanced user experiences. We'll explore how entering the AI-driven search market through the Perplexity deal could...
NYSE:EBS
NYSE:EBSBiotechs

Emergent BioSolutions (EBS): Evaluating Valuation After Raised 2025 Guidance and Strong Q3 Results

Emergent BioSolutions (EBS) captured investors' attention after reporting third-quarter results that topped revenue and profitability expectations. Management responded by raising full-year 2025 revenue and adjusted EBITDA guidance following these strong results. See our latest analysis for Emergent BioSolutions. Emergent BioSolutions has staged a remarkable turnaround lately, with a 36% jump in its 1-month share price return and an eye-catching 110% surge over the last 90 days. This rapid...
NYSE:ACH
NYSE:ACHHealthcare

Owens & Minor (OMI): Valuation Outlook Following Strategic Shift to Patient Direct and Optum Health Partnership

Owens & Minor (OMI) is shifting its strategy in a big way, rebranding to center entirely around its Patient Direct business after selling off its Products & Healthcare Services segment. The company’s new agreement with Optum Health signals a fresh phase for its home-based care ambitions. See our latest analysis for Owens & Minor. Despite management’s renewed focus and the headline Optum Health partnership, the stock has taken a heavy hit this year. Owens & Minor’s share price has dropped 69%...
NYSE:SWX
NYSE:SWXGas Utilities

Is Southwest Gas Holdings Share Price Justified After 13% Rally and Infrastructure Investment News?

Curious if Southwest Gas Holdings is a hidden gem or just priced for perfection? You are not alone in wanting to know whether the current share price truly reflects the company's value. After climbing 13.1% year-to-date and 14.1% over the last year, Southwest Gas Holdings’ stock has sparked conversations about renewed growth and possible shifts in risk perception. Recently, headlines have focused on the company’s ongoing efforts in infrastructure improvements and regulatory updates. These...
NYSE:LYB
NYSE:LYBChemicals

LyondellBasell (LYB): Unprofitable Status and Widening Losses Challenge Turnaround Narrative

LyondellBasell Industries (LYB) reported widening losses, with net profit margins and earnings quality reflecting its unprofitable status. Over the past five years, annual losses have grown by 24.8% per year and year-over-year profit growth is unavailable due to continued unprofitability. Looking ahead, the company forecasts earnings growth of 52.66% per year and expects to return to profitability within three years, despite revenue projections showing a 7.1% annual decline. See our full...
NYSE:SPR
NYSE:SPRAerospace & Defense

Spirit AeroSystems (SPR): Persistent Losses Challenge Bullish Recovery Narrative Despite Revenue Growth Forecast

Spirit AeroSystems Holdings (SPR) remains in the red, with annualized losses growing at 32.5% over the past five years and no sign of current profitability. Despite the negative margin trends, revenue is forecast to climb 14.2% per year, surpassing the US market’s expected 10.4% pace. EPS is projected to jump 88.11% yearly and the company anticipates returning to profit within three years. Investors weighing these results are balancing hefty growth projections and a deeply discounted share...